| Title | Advances in Rheumatology |
| Standard Abbreviation | Adv. Rheumatol. |
| Type of Publication | Journal |
| Discipline | Rheumatology (Q3) |
| Impact Score | 2.08 |
| SCImago Journal Rank (SJR) | 0.686 |
| h-index | 35 |
| Overall Rank | 7287 |
| Publisher Name | BioMed Central Ltd. |
| Publication Country | United Kingdom |
| International Standard Serial Number (ISSN) | 25233106 |
| Coverage and History | 2018-2022 |
| Best Quartile | Q3 |
| Total Citations Received (Last 3 Year) |
485 |
Advances in Rheumatology is a journal published by BioMed Central Ltd.. This journal covers the area[s] related to Rheumatology, etc.
The coverage history of this journal is as follows: 2018-2022.
The rank of this journal is 7287. This journal's impact score, h-index, and SJR are 2.08, 35, and 0.686, respectively. The ISSN of this journal is/are as follows: 25233106.
The best quartile of Advances in Rheumatology is Q3.
This journal has received a total of 485 citations during the last three years (Preceding 2022).
The latest impact score (IS) of the Advances in Rheumatology is 2.08. It is computed in the year 2023 as per its definition and based on Scopus data.
2.08
It is decreased by a factor of around 0.63, and the percentage change is -23.25% compared to the preceding year 2021, indicating a falling trend.
The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact Score 2022 of Advances in Rheumatology is 2.08. If a similar downward trend continues, IS may decrease in 2023 as well.
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.08 |
| 2021 | 2.71 |
| 2020 | 1.96 |
| 2019 | 1.31 |
| 2018 | 0.99 |
| 2017 | 1.10 |
| 2016 | 0.78 |
| 2015 | 0.90 |
| 2014 | 1.09 |
The h-index of Advances in Rheumatology is 35. By definition of the h-index, this journal has at least 35 published articles with more than 35 citations.
The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.
The International Standard Serial Number (ISSN) of Advances in Rheumatology is/are as follows: 25233106.
The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.
ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}
The Advances in Rheumatology is ranked 7287 among 27955 Journals, Conferences, and Book Series.
As per SJR, this journal is ranked 0.686.
SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
The publisher of Advances in Rheumatology is BioMed Central Ltd.. The publishing house of this journal is located in the United Kingdom. Its coverage history is as follows: 2018-2022.
Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).
The International Organization for Standardization 4 (ISO 4) abbreviation of
2.08
0.686
35
7287
